Phlegmasia cerulea dolens - an uncommon but alarming manifestation of deep vein thrombosis.

In phlegmasia cerulea dolens (PCD), immediate diagnosis and prompt treatment is crucial for limb salvage. Aggressive treatment options including venous intervention, thrombolysis and/or surgical thrombectomy should be considered. Due to the lack of data, the most appropriate intervention depends upon etiology of PCD, clinical presentation and patient's bleeding risk.

Patients' Views on Regional Anesthesia for Elective Unilateral Carotid Endarterectomy--A Prospective Cohort Study.

BACKGROUND: Carotid endarterectomy (CEA) can be performed under general anesthesia (GA) or locoregional anesthesia (LA). However, the patients' views on the choice between GA and LA are currently poorly understood. We aimed at identifying the preoperative patient information needs, their role in decision-making, and influencing factors associated with LA and anxiety regarding surgery and anesthesia in CEA as a base for improving preoperative consultation and decision-making in the informed consent process. METHODS: Data were collected from consecutive patients undergoing unilateral elective CEA. Data on basic demographics, preoperative information needs, factors influencing decision-making concerning anesthesia technique, a Mini Mental State Examination (MMSE), a Visual Analog Scale (VAS), and the State-Trait Anxiety Inventory (STAI-T/S) were collected. RESULTS: A total of 59 patients were included in the study, 10 women and 49 men, with a median age of 71 years (interquartile range, 66-77 years). Fifty-four (92%) patients assessed the surgeons' given information as adequate. Older patients (>70 years, n = 31) had less self-conception of anxiety compared to younger patients (≤70 years, n = 28), 3% vs. 21%, P = 0.045. Males expressed less anxiety regarding "waking up during general anesthesia" compared to females (0% vs. 30%, P < 0.001). Anxiety about anesthesia and surgery as measured by VAS highly correlated with the STAI-S scores (Pearson correlation coefficient [CC], 0.45; 95% confidence interval [CI], 0.18-0.66, P < 0.001; CC, 0.47; 95% CI, 0.27-0.66, P < 0.001, respectively). Patients with a lower cognitive function (MMSE ≤27, n = 20) had lower needs for preoperative medical information compared to patients with MMSE >27 (n = 36), 0% vs. 15%, P = 0.042. Two (3%) patients received GA because of their previous bad experience with LA. CONCLUSIONS: Younger and female patients may benefit from a more detailed and reassuring informed consent process. All institutions should use procedure-specific informed consent forms as they appear to be very adequate for the patient information needs. Nearly all patients are willing to undergo LA with the exception of those having had previous bad experience with LA for CEA.

[Postoperative care following vascular surgery - control of risk factors and guide-lines for physicians in charge of vascular patients]. / Die postoperative Betreuung nach gefäßchirurgischem Eingriff - Sekundärprophylaxe und Richtlinien für den Hausarzt.

Patients after major vascular surgery operations present with different problems. Therefore dedicated physicians and good communication between surgeon and physician are required. One of the main goals should be control of cardiovascular risk factors. The following article presents an overview of common vascular operations and proposes guide-lines for postoperative care.

Ten years after arterial bypass surgery for claudication: venous bypass is the primary procedure for TASC C and D lesions.

BACKGROUND: The appropriate role for surgery and endovascular therapy for severe intermittent claudication (IC) remains controversial. We present our results after infrainguinal autogenous bypass for severe IC more than 10 years ago giving a reasoned argument to perform vein bypass as the primary procedure for severe IC. METHODS: Our prospectively designed database includes more than 1,000 infrainguinal bypasses following an all-autogenous policy. For this review only patients operated on for severe IC at least 10 years ago were included. The primary end points were survival and primary and assisted-primary patency rates. RESULTS: From October 1988 until December 2000, 124 bypasses for IC were performed. Ninety-five patients were male and the mean age was 64.5 ± 10.8 years. Survival after 10 years was 50.3% according to life table analysis. Forty bypasses were to the supragenicular artery, 62 to the infragenicular popliteal artery, and 22 to the tibial artery. Thirty-day mortality was 0.8% (1 patient). The primary patency rate after 10 years was 63.5% and the assisted-primary patency rate 87.3%. CONCLUSION: Infrainguinal venous bypass for severe IC has excellent long-term results. Our results are strong arguments against the liberal use of stenting long lesions of the femoropopliteal artery. Venous bypass remains the primary procedure for TASC C and D lesions in claudicants.

Endarterectomy of the aneurysm sac in open abdominal aortic aneurysm repair reduces perigraft seroma and improves graft incorporation.

BACKGROUND: Fluid around the graft in the original aneurysm sac after open abdominal aortic aneurysm (AAA) repair is a poorly researched phenomenon. If large, such perigraft seroma can cause symptoms of compression, and cases of rupture have even been described. We assessed whether endarterectomy of the aneurysm sac reduces the incidence of perigraft fluid and improves graft incorporation. DESIGN AND METHODS: Starting in July 2005, all patients with elective open AAA repair were alternately treated either with conventional thrombectomy or thrombectomy plus endarterectomy of the aneurysm sac. All patients were treated with a polytetrafluoroethylene (PTFE) graft. The maximum axial width of the perigraft fluid collection was measured on computed tomography (CT) scans 1 year after operation. RESULTS: The CT scans of 115 patients were available; 56 had endarterectomy of the aneurysm sac and 59 did not. Fluid collections were significantly smaller in patients with endarterectomy (median width 4.0 versus 8.0 mm; P = 0.0001). Eight patients with endarterectomy had a fluid collection wider than 10 mm compared to 28 patients without endarterectomy (OR 0.18, 95% CI 0.07-0.46). After endarterectomy, 17 patients had radiological signs of complete graft incorporation in comparison to only 6 patients without endarterectomy (OR 3.85, 95% CI 1.39-10.66). No patients were symptomatic or reoperated for perigraft seroma. CONCLUSIONS: Endarterectomy of the aneurysm sac in open AAA repair appears to improve graft incorporation. The high rate of asymptomatic perigraft seroma is surprising, and its clinical significance is unknown. Ultrafiltration of PTFE grafts may be an underlying mechanism.

Transposition of the persistent sciatic artery for lower limb revascularization after resection of an embolizing proximal sciatic artery aneurysm.

We present a novel surgical technique for lower limb revascularization after resection of an aneurysm of the persistent sciatic artery that had led to recurrent peripheral embolization and severe ischemia. The superficial femoral artery in this patient was hypoplastic, and the sciatic artery continued into the popliteal artery as the source of blood supply to the lower leg. For revascularization, we used the distally pedicled healthy two-thirds of the persistent sciatic artery, transposed it from its posterior position to a nearly anatomic anteromedial position, and anastomosed it to the proximal superficial femoral artery.

New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS).

BACKGROUND: The International Carotid Stenting Study (ICSS) of stenting and endarterectomy for symptomatic carotid stenosis found a higher incidence of stroke within 30 days of stenting compared with endarterectomy. We aimed to compare the rate of ischaemic brain injury detectable on MRI between the two groups. METHODS: Patients with recently symptomatic carotid artery stenosis enrolled in ICSS were randomly assigned in a 1:1 ratio to receive carotid artery stenting or endarterectomy. Of 50 centres in ICSS, seven took part in the MRI substudy. The protocol specified that MRI was done 1-7 days before treatment, 1-3 days after treatment (post-treatment scan), and 27-33 days after treatment. Scans were analysed by two or three investigators who were masked to treatment. The primary endpoint was the presence of at least one new ischaemic brain lesion on diffusion-weighted imaging (DWI) on the post-treatment scan. Analysis was per protocol. This is a substudy of a registered trial, ISRCTN 25337470. FINDINGS: 231 patients (124 in the stenting group and 107 in the endarterectomy group) had MRI before and after treatment. 62 (50%) of 124 patients in the stenting group and 18 (17%) of 107 patients in the endarterectomy group had at least one new DWI lesion detected on post-treatment scans done a median of 1 day after treatment (adjusted odds ratio [OR] 5.21, 95% CI 2.78-9.79; p<0.0001). At 1 month, there were changes on fluid-attenuated inversion recovery sequences in 28 (33%) of 86 patients in the stenting group and six (8%) of 75 in the endarterectomy group (adjusted OR 5.93, 95% CI 2.25-15.62; p=0.0003). In patients treated at a centre with a policy of using cerebral protection devices, 37 (73%) of 51 in the stenting group and eight (17%) of 46 in the endarterectomy group had at least one new DWI lesion on post-treatment scans (adjusted OR 12.20, 95% CI 4.53-32.84), whereas in those treated at a centre with a policy of unprotected stenting, 25 (34%) of 73 patients in the stenting group and ten (16%) of 61 in the endarterectomy group had new lesions on DWI (adjusted OR 2.70, 1.16-6.24; interaction p=0.019). INTERPRETATION: About three times more patients in the stenting group than in the endarterectomy group had new ischaemic lesions on DWI on post-treatment scans. The difference in clinical stroke risk in ICSS is therefore unlikely to have been caused by ascertainment bias. Protection devices did not seem to be effective in preventing cerebral ischaemia during stenting. DWI might serve as a surrogate outcome measure in future trials of carotid interventions. FUNDING: UK Medical Research Council, the Stroke Association, Sanofi-Synthélabo, European Union, Netherlands Heart Foundation, and Mach-Gaensslen Foundation.

Combined abdominal aortic aneurysm repair and coronary artery bypass: presentation of 13 cases and review of the literature.

Coronary artery disease remains the major cause of perioperative mortality after abdominal aortic aneurysm (AAA) repair. The beneficial effect of coronary artery bypass (CAB) before AAA repair in patients with severe coronary artery disease has been proven. The coexistence of a very large or symptomatic AAA and coronary artery disease remains a therapeutic challenge since there is the risk of AAA rupture in the interval between CAB and AAA repair. Combined CAB and aortic aneurysm repair has been suggested for these cases, and results on several series of patients have been published. However, the exact indication for the combined operation remains to be clarified. We present a series of 13 patients who underwent CAB on cardiopulmonary bypass and aortic aneurysm repair as a one-stage procedure. The indication was a large AAA in seven patients and a symptomatic AAA in six patients. In four patients, the aortic reconstruction was performed without the use of cardiopulmonary bypass; in nine patients, the aortic reconstruction was performed under partial cardiopulmonary bypass. Thirty-day mortality was 15%. Major morbidity was 31%. All major complications were due to excessive bleeding and occurred in patients who had AAA repair performed with partial cardiopulmonary bypass, suggesting that prolonged bypass time represents a major source of morbidity. A detailed review of the literature is presented. From the evidence available we suggest that the combined procedure can be recommended only for patients with very high rupture risk, such as in symptomatic AAA. In all other cases, the staged approach--CAB followed by AAA repair 2-4 weeks later--is preferable. During the combined procedure, cardiopulmonary bypass support during AAA repair should be used only in patients with clear evidence of hemodynamic instability.

Major vascular resection and prosthetic replacement for retroperitoneal tumors.

INTRODUCTION: Involvement of major vascular structures has been considered a limiting factor for resecting advanced tumors. The objective of this study was to evaluate the outcome after concomitant retroperitoneal tumor and vascular resection with prosthetic replacement of the aorta/vena cava. METHODS: The authors reviewed a 5-year series of eight patients with a median age of 50 years (range 11-68 years) who had undergone resection of a retroperitoneal tumor and concomitant resection and replacement of the abdominal aorta, inferior vena cava, or both. The histologic diagnoses were sarcoma (five patients), teratoma (one), transitional cell carcinoma (one), and ganglioneuroma (one). The main outcome measures were early (<30 days) and late (>or=30 days) surgical morbidity and mortality. Secondary endpoints were vascular graft patency and tumor-free survival. Two patients underwent combined graft replacement of the aorta and vena cava. Single aortic and vena cava graft replacement were each done in three patients. RESULTS: Two patients showed early surgical morbidity necessitating reoperation for a thrombotic graft occlusion. No patient died during the early course of the follow-up. During a median follow-up of 14 months (range 1-56 months), two patients had late surgical morbidity. The median tumor-free survival for patients with malignancy was 14 months (range 1-54 months). One patient developed locoregional tumor recurrence, and two developed distant metastases. The median survival for patients with malignancy was 14 months (range 1-60 months). CONCLUSIONS: An aggressive surgical approach for otherwise unresectable retroperitoneal tumors with vascular resection and prosthetic vascular replacement is justified in selected cases and has acceptable morbidity and mortality.

Acute supramesenteric thrombosis of an abdominal aortic aneurysm with deleterious embolism: a case report.

A 55-year-old man was admitted with severe pain, paralysis of both legs and absent femoral pulses. Computed tomographic scan demonstrated a 6 cm juxtarenal abdominal aortic aneurysm (AAA) with thrombosis starting at the level of the celiac trunk. At immediate operation, thrombectomy of visceral arteries was performed and distal neovascularization was achieved with a bifurcated prosthesis. It was revealed that all major arteries were occluded with debris. Embolectomy did restore flow in major vessels, but organ perfusion was not achieved due to occlusion of smaller vessels. The patient died with multiorgan failure. This is the first description in the literature of an acutely thrombosed AAA at the supramesenteric level.

Endovascular stent graft for symptomatic mobile thrombus of the thoracic aorta.

Mobile thoracic aortic thrombus is a potential source of arterial embolism. Therapeutic management remains controversial. Systemic anticoagulation and various open surgical procedures are the commonly used therapeutic modalities. We report the successful primary treatment by endovascular stent graft of a mobile thoracic aortic thrombus that had caused visceral and peripheral embolism. Our case shows that endovascular stent-graft treatment is an effective, minimally invasive treatment of symptomatic mobile thoracic aortic thrombus.

Does specialization improve outcome in abdominal aortic aneurysm surgery?

Specialization and high volume are reported to be related to a better outcome after abdominal aortic aneurysm repair. The aim of this study was to compare, in patients undergoing abdominal aortic aneurysm repair, the outcomes of those whose surgery was done by general surgeons with the outcomes of those whose surgery was done by specialist vascular surgeons. All patients undergoing abdominal aortic aneurysm repair at the Basel University Hospital (referral center) from January 1990 to December 2000 were included. Patients with endovascular treatment were excluded. Operations in group A (n = 189), between January 1990 and May 1995, were done by general surgeons. Operations in group B (n = 291), between June 1995 and December 2000, were done by vascular surgeons. In-hospital mortality and local and systemic complications were assessed. In-hospital mortality rates were significantly lower for group B (with specialist surgeons) than for group A, both overall (group B, 11.7%; group A, 21.7%; p = .003) and for emergency interventions (group B, 28.1%; group A, 41.9%; p = .042). The reduction in mortality for elective surgery in group B was not statistically significant (group B, 1.1%; group A, 4.9%; p = .054). There were significantly fewer pulmonary complications in group B compared with group A (p = .000). We conclude that in patients undergoing abdominal aortic aneurysm repair, those whose surgery is done by a specialized team have a significantly better outcome than those whose surgery is done by general surgeons.

CT-guided percutaneous embolization of a lumbar artery maintaining a type II endoleak.

PURPOSE: To demonstrate the possibility of percutaneous embolization of a type II endoleak guided by computed tomographic (CT) fluoroscopy. CASE REPORT: A type II endoleak maintained by a hypertrophic fourth lumbar artery failed to occlude spontaneously 7 months after stent-graft deployment for endovascular repair of an infrarenal abdominal aortic aneurysm. A percutaneous procedure was performed to eliminate the endoleak using needle puncture and embolization under CT fluoroscopic guidance. The sagittal diameter of the aneurysm sac, which had remained constant after initial endovascular exclusion, shrank from 5.2 to 4.8 cm in the 3 months following embolization. CONCLUSIONS: Percutaneous embolization of lumbar branches guided by CT fluoroscopy may be an alternative to other therapies for type II endoleaks.

Brachial artery dilatation after arteriovenous fistulae in patients after renal transplantation: a 10-year follow-up with ultrasound scan.

BACKGROUND: Dilatation of the artery proximal to arteriovenous fistula (AF) is not well known but is a potential serious complication in patients for renal transplant. METHODS: From 1991 until 2001, the diameters of the brachial arteries of 29 patients after successful renal transplantation and with existing AF were prospectively evaluated with ultrasound scan. Nine patients with longstanding AF without transplantation were included as a control group. RESULTS: In 1991, the mean brachial artery diameter was 6.4 mm (+/-1.8 mm) with patent AF and 5.2 mm (+/-1.5 mm) with occluded AF (P= not significant). The 1994 mean diameter was 6.6 mm (+/-1.7 mm) versus 5.3 mm (+/-2.0 mm; P =.029). In 2001, the mean diameter rose to 7.4 mm (+/-1.3 mm) versus 5.7 mm (+/-2.8 mm; P =.022). Compared with the side without fistula, the diameter of brachial artery on the AF side was significantly greater during the whole study period. The increase in the diameter correlates significantly with the time the AF had been patent (P =.001, according to Spearman test). The dilatation of the brachial arteries of patients without transplantation was smaller compared with patients after transplantation but did not reach statistical significance. Two patients had to undergo operation on a symptomatic aneurysm of the axillobrachial artery. CONCLUSION: According to our results, dilatation of the brachial artery after AV is time dependent. Higher flow in the AF seems to be the main trigger of dilatation.

Mural thrombus of the aorta in association with homozygous plasminogen activator inhibitor type 1 (PAI-1)-675(4G) and heterozygous GP Ia 807C/T genotypes.

Thrombus formation in the thoracic and abdominal aorta without evidence of arteriosclerotic disease is very uncommon. We present a case of a 50-year-old woman with a mural thrombus of the upper abdominal aorta associated with a combination of two mutations predisposing for thrombophilia. The genetic analysis showed a homozygous mutation of plasminogen activator inhibitor type 1 (PAI-1)-675 (4G) and a heterozygous mutation of GP Ia 807C/T. To our knowledge, this is the first report of the combination of both mutations occurring in a patient with isolated thrombus formation of the aorta.